Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC102724927 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FGFBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TOMM20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102723661 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF138 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP20A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEX3D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OLAH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC19A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCT6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SVOP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR622 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RETN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HBB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRMT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on